SCLT1 Antibody

What is SCLT1 and why is it important in cellular research?

SCLT1 (Sodium Channel and Clathrin Linker 1) is an adaptor protein that links SCN10A to clathrin and serves as a critical component of centriolar distal appendages (DAPs). It plays essential roles in ciliogenesis by facilitating the docking of ciliary vesicles to the mother centriole . Mutations in SCLT1 have been linked to oral-facial-digital syndrome type IX and other ciliopathies . The protein is widely expressed across many tissue types, making SCLT1 antibodies valuable tools for studying ciliary development, function, and related pathologies.

What applications are SCLT1 antibodies validated for?

SCLT1 antibodies have been validated for multiple applications:

Note: Optimal dilutions should be determined experimentally for each specific application and sample type .

What is the molecular weight of SCLT1 protein and what bands should I expect in Western blot?

• 75-80 kDa band corresponding to the full-length protein

• 36 kDa band possibly representing a shorter isoform or proteolytic fragment

This variation may reflect the existence of up to four different isoforms reported for this protein . Always include positive controls (such as HEK-293 cells, mouse brain tissue, or HeLa cells) for proper band identification.

How should I optimize SCLT1 antibody staining for immunofluorescence of primary cilia?

For optimal immunofluorescence staining of SCLT1 at primary cilia:

• Cell preparation:

  • Culture cells on glass coverslips to 70-80% confluency

  • Induce ciliogenesis by serum starvation (0.5% FBS) for 24-48 hours

• Fixation method:

  • For optimal preservation of centriolar structures, use cold methanol fixation (5 minutes at -20°C)

  • Alternatively, use 4% paraformaldehyde for 10 minutes followed by 0.1% Triton X-100 permeabilization

• Antibody incubation:

  • Block with 3-5% BSA in PBS for 30-60 minutes

  • Dilute SCLT1 antibody 1:300-1:1200 in blocking solution

  • Co-stain with basal body marker (γ-tubulin) and ciliary marker (Arl13b)

  • Include DAPI for nuclear counterstaining

• Imaging considerations:

  • Use confocal or super-resolution microscopy for optimal visualization

  • Z-stack imaging is recommended to capture the full ciliary structure

Research demonstrates that SCLT1 localizes specifically to the transition zone between the basal body and ciliary axoneme, making it an excellent marker for studying cilia formation dynamics .

How can I validate the specificity of my SCLT1 antibody?

To ensure the specificity of your SCLT1 antibody, implement a multi-tiered validation approach:

• Gene knockout/knockdown controls:

  • Compare staining patterns between wildtype and SCLT1 knockout/knockdown cells

  • CRISPR-Cas9 knockout or siRNA-mediated knockdown systems are recommended

• Peptide competition assay:

  • Pre-incubate antibody with immunizing peptide (AA 576-605 for C-terminal antibodies)

  • Specific signal should be abolished with excess peptide

• Cross-validation with multiple antibodies:

  • Test antibodies against different epitopes (N-terminal vs. C-terminal)

  • Compare polyclonal and monoclonal antibody staining patterns

• Heterologous expression system:

  • Transfect cells with tagged SCLT1 constructs

  • Co-localization of antibody signal with tag signal confirms specificity

• Orthogonal validation:

  • Compare protein expression with RNA expression data from scRNA-seq

  • Research shows correlation coefficients of 0.38-0.58 between antibody and RNA expression levels for cell surface markers

What are the best co-staining markers to use with SCLT1 for cilia research?

For comprehensive analysis of cilia structure and function with SCLT1:

For detailed analysis of DAP assembly, hierarchical staining is crucial. Research shows that SCLT1 functions downstream of CEP83 but upstream of CEP164 and FBF1 in the DAP assembly pathway . This hierarchical relationship should be evident in properly executed co-staining experiments.

How does SCLT1 antibody staining pattern change during the cell cycle and ciliogenesis?

The localization of SCLT1 undergoes dynamic changes during cell cycle progression and ciliogenesis:

Recent research using transmission electron microscopy and super-resolution imaging has revealed that SCLT1 plays a critical role in the recruitment of preciliary vesicles to the distal end of the mother centriole, with approximately 50% reduction in ciliary vesicle docking in SCLT1 mutant cells .

How can SCLT1 antibodies be used to investigate tissue-specific ciliogenesis defects?

SCLT1 antibodies are valuable tools for investigating tissue-specific ciliogenesis requirements, as revealed by recent knockout studies:

• Tissue collection and preparation:

  • Collect tissues of interest from wildtype and SCLT1 mutant/conditional knockout models

  • For embryonic studies, E10.5-E11.5 limb buds show differential phenotypes between fore- and hindlimbs

  • Process tissues for paraffin embedding using standard histological protocols

• Immunohistochemical analysis:

  • Perform antigen retrieval (TE buffer pH 9.0 recommended)

  • Stain with SCLT1 antibody (1:600-1:2400 dilution)

  • Co-stain with ciliary markers (Arl13b) and tissue-specific markers

• Quantitative assessment:

  • Count percentage of ciliated cells in different tissues

  • Measure cilia length and morphology

  • Compare DAP recruitment patterns across tissue types

Research has demonstrated that SCLT1 mutant mice exhibit tissue-specific ciliogenesis defects, with hindlimb mesenchymal cells showing approximately 50% reduction in ciliogenesis compared to normal ciliogenesis in forelimb cells . This differential requirement for SCLT1 in ciliogenesis correlates with tissue-specific developmental abnormalities, such as preaxial polydactyly specifically in hindlimbs.

What is the relationship between SCLT1 and other distal appendage proteins in ciliary assembly?

SCLT1 functions within a hierarchical assembly pathway of distal appendage proteins:

For investigating this hierarchy, it's recommended to use SCLT1 antibodies in combination with other DAP antibodies in genetic knockout/knockdown systems to establish dependency relationships.

Why am I seeing variable SCLT1 staining patterns across different cell types?

Variable SCLT1 staining can result from several biological and technical factors:

• Tissue-specific expression levels:

  • SCLT1 expression varies across tissues

  • Limb bud mesenchymal cells show differential SCLT1 requirement between fore- and hindlimbs

• Isoform variations:

  • Up to four different SCLT1 isoforms have been reported

  • Different antibodies may recognize specific isoforms preferentially

• Cell cycle and ciliation state:

  • SCLT1 localization changes during ciliogenesis

  • Serum starvation triggers redistribution from periphery to root of DAPs

• Technical considerations:

  • Fixation method significantly impacts DAP protein detection

  • Methanol fixation often preserves centriolar structures better than paraformaldehyde

  • Antibody dilution may need optimization for each cell type (1:300-1:1200 range)

If experiencing variable staining, consider using multiple SCLT1 antibodies targeting different epitopes and implementing comprehensive controls for each cell type being examined.

How can I use SCLT1 antibodies to study ciliopathies in patient-derived samples?

For ciliopathy research using patient samples:

• Sample collection and processing:

  • Obtain appropriate ethical approvals and informed consent

  • Collect patient fibroblasts from skin biopsies

  • Alternatively, generate patient-specific iPSCs and differentiate into relevant cell types

• Immunofluorescence analysis:

  • Induce ciliation through serum starvation (0.5% FBS, 24-48h)

  • Stain with SCLT1 antibody (1:300-1:1200) and ciliary markers

  • Quantify percentage of ciliated cells, cilia length, and SCLT1 localization

• Biochemical characterization:

  • Perform Western blot analysis (1:1000-1:6000 dilution)

  • Compare SCLT1 protein levels between patient and control samples

  • Assess other DAP components to determine if there's a hierarchical disruption

• Functional studies:

  • Analyze Hedgehog signaling activity in patient cells

  • Research shows SCLT1 defects impair GLI3 processing and Hedgehog target gene expression

  • Use Smoothened agonist (SAG) treatment to evaluate pathway responsiveness

SCLT1 mutations have been linked to oral-facial-digital syndrome type IX, characterized by midline cleft palate, microcephaly, and coloboma . Examining SCLT1 localization and ciliogenesis in patient cells can provide insights into disease mechanisms.

How can I optimize SCLT1 antibody for super-resolution microscopy?

For optimal SCLT1 imaging using super-resolution techniques:

• Sample preparation considerations:

  • Use high-quality #1.5 coverslips (0.17mm thickness)

  • For STORM/PALM: Consider photoconvertible fluorophore-labeled secondary antibodies

  • For STED: Use STED-compatible fluorophores like STAR635P or ATTO647N

• Antibody optimization:

  • Use lower primary antibody concentrations (1:800-1:1200)

  • Shorter incubation times may reduce background

  • Consider directly conjugated antibodies to eliminate secondary antibody distance

• Imaging parameters:

  • For structural illumination microscopy (SIM): Use 100-120nm grid patterns

  • For STORM: Ensure proper buffering systems with oxygen scavengers

  • For STED: Optimize depletion laser power to balance resolution and photobleaching

• Multi-color considerations:

  • Use spectral unmixing for closely spaced fluorophores

  • Sequential imaging may be necessary to prevent fluorophore interactions

  • Include reference markers for channel alignment

Research using super-resolution microscopy has revealed that SCLT1 forms a nine-fold symmetric arrangement around the mother centriole, with redistribution during early ciliogenesis from the periphery toward the root of DAPs . This level of detail is only accessible through super-resolution techniques.

How can multiplexed antibody approaches be used to study SCLT1 in complex tissue environments?

Recent advances in multiplexed imaging enable comprehensive analysis of SCLT1 in tissue contexts:

• Imaging Mass Cytometry (IMC) approach:

  • Conjugate SCLT1 antibody to heavy metal isotopes

  • Combine with up to 40 other antibodies for simultaneous detection

  • Process tissue sections following standardized protocols

  • Analyze using single-cell quantification and clustering

• Cyclic Immunofluorescence (CycIF):

  • Perform repeated rounds of staining, imaging, and signal erasing

  • Include SCLT1 in appropriate staining round alongside contextual markers

  • Computational alignment enables multi-marker analysis

• Spatial transcriptomics integration:

  • Correlate SCLT1 protein expression with mRNA patterns

  • Research shows correlations of 0.38-0.58 between protein and RNA levels

  • Use computational approaches to identify co-regulated gene modules

• Data analysis considerations:

  • Apply machine learning for cell type identification

  • Implement clustering to identify tissue-specific SCLT1 expression patterns

  • Correlate with functional annotations for biological interpretation

Recent research has validated the use of multiplexed antibody panels designed from single-cell RNA-seq data for spatial profiling of tissue subpopulations, with novel markers showing expected tissue localization patterns .

What are the emerging approaches for studying SCLT1 phosphorylation dynamics during ciliogenesis?

Phosphorylation plays a critical role in regulating SCLT1 function during ciliogenesis:

• Phospho-specific antibody development:

  • Generate antibodies specific to phosphorylated SCLT1 residues

  • Key sites may include those phosphorylated by TTBK2, a kinase essential for ciliogenesis

• Live-cell imaging approaches:

  • Develop FRET-based sensors for SCLT1 phosphorylation state

  • Use fluorescently tagged SCLT1 constructs with phospho-mimetic mutations

• Mass spectrometry-based phosphoproteomics:

  • Immunoprecipitate SCLT1 from ciliated vs. non-ciliated cells

  • Perform phosphopeptide enrichment and LC-MS/MS analysis

  • Compare phosphorylation profiles during ciliogenesis progression

• Kinase-substrate relationship studies:

  • Investigate the role of TTBK2 in potential SCLT1 phosphorylation

  • Research shows TTBK2 phosphorylates the DAP component CEP83

  • Similar phosphorylation events may regulate SCLT1 function

Recent studies have identified phosphorylation of CEP83 by TTBK2 as necessary for cilia initiation , suggesting that similar regulatory mechanisms may govern SCLT1 function within the distal appendage assembly pathway.

What resources are available for validating and troubleshooting SCLT1 antibodies?

For comprehensive SCLT1 antibody validation and troubleshooting:

• Publicly available databases:

  • Human Protein Atlas: Contains validation data for SCLT1 antibodies

  • Antibodypedia: Collates user experiences and validation data

  • CiteAb: Provides citation metrics for antibody performance

• Reference materials:

  • Positive control cell lines: HEK-293, HeLa, and hTERT-RPE1 cells

  • Positive control tissues: Human colon cancer tissue, brain tissue

  • Recombinant SCLT1 protein fragments for peptide competition assays

• Protocol repositories:

  • Protocols.io: Contains detailed IHC/IF protocols for cilia markers

  • Benchsci: Aggregates published uses of specific antibodies

• Community resources:

  • Research forums such as ResearchGate for troubleshooting

  • Specialized ciliopathy research networks and consortia

  • Manufacturer technical support services